What is Abingdon Health Plc?
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally.
ABDXF · Verdict
Moderate reward · elevated risk
ABDXF stands out on volatility and growth, but watch the cash flow signal.
Based on 88% data coverage
ABDXF · Verdict
Top decile vs peers
Rev +43.8% CAGR · earnings -45.6%
-42% free-cash-flow margin
-41% net margin · -63% ROE
Model-based scoring. For information only — not financial advice.
Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 13.27M.
The scoring profile indicates limited reward potential at this time, with growth and valuation offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.
For informational purposes only. Not financial advice.